Cita APA

YN, A., A, F., M, G., C, Z., M, R., EM, C., . . . M, M. (2025). Transcriptomic Predictors of Survival for Palbociclib plus Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

Citación estilo Chicago

YN, Agrawal, et al. Transcriptomic Predictors of Survival for Palbociclib Plus Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial. 2025.

Cita MLA

YN, Agrawal, et al. Transcriptomic Predictors of Survival for Palbociclib Plus Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial. 2025.